CN117153324A - Medicine preparation control method, device, equipment and storage medium - Google Patents
Medicine preparation control method, device, equipment and storage medium Download PDFInfo
- Publication number
- CN117153324A CN117153324A CN202311379288.3A CN202311379288A CN117153324A CN 117153324 A CN117153324 A CN 117153324A CN 202311379288 A CN202311379288 A CN 202311379288A CN 117153324 A CN117153324 A CN 117153324A
- Authority
- CN
- China
- Prior art keywords
- medicine
- dose
- preparation
- dosage
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 645
- 238000002360 preparation method Methods 0.000 title claims abstract description 248
- 238000000034 method Methods 0.000 title claims abstract description 41
- 238000003860 storage Methods 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 title claims description 57
- 239000002994 raw material Substances 0.000 claims abstract description 60
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 229940127557 pharmaceutical product Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 238000004891 communication Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/06—Buying, selling or leasing transactions
Landscapes
- Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- Health & Medical Sciences (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Epidemiology (AREA)
- Economics (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Development Economics (AREA)
- General Health & Medical Sciences (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The application discloses a medicine preparation control method, a device, equipment and a storage medium, wherein the method comprises the steps of obtaining medicine historical selling information of a plurality of medicine selling main bodies in different areas; establishing a dose influence factor list according to selling associated information corresponding to each medicine dose theoretical value of the target medicine; and adjusting the actual value of the medicine dosage in the medicine selling period corresponding to the latest medicine preparation period by using the dosage influence factor list to obtain the medicine dosage preparation strategy of the current medicine preparation period to execute medicine preparation. According to the application, the medicine dose preparation strategy of the current medicine preparation period is obtained by establishing the dose influence factor list and then adjusting the actual value of the medicine dose of the latest medicine paper cup period, so that the management fineness of the Tibetan medicine raw materials is improved, each patient can buy the Tibetan medicine dose which is most suitable for the state of the patient, the suitability of the Tibetan medicine dose is improved, the medicine effect of the Tibetan medicine is further enhanced, and the Tibetan medicine price is further reduced.
Description
Technical Field
The application relates to the technical field of Tibetan medicine preparation, in particular to a medicine preparation control method, a device, equipment and a storage medium.
Background
The Tibetan medicinal plants are mostly distributed among alpine meadow vegetation, mountain pad-shaped vegetation and mountain waterstone beach sparse vegetation above the altitude 3800 meters. Wherein the vertical division is a main source of herbal medicine in regions with the height of 4200 meters to 4800 meters. The mountain and water stone beach under the permanent ice and snow belt with the altitude of 4800 meters is accumulated with fine sand grains in the broken stone gaps due to the strong chill and physical weathering, thus creating possible conditions for the growth and development of mountain plants. Because of high cold and hypoxia, particularly strong solar radiation, very rich blue-violet light and ultraviolet light, clear air, less dust matters, low water vapor content, contribution to light passing, full photosynthesis of plants under the action of different enzymes, high accumulation of medicinal effective substances and strong biological activity, and other regional advantage conditions besides the plateau are important reasons for strong and pure Tibetan medicines and ideal curative effects. Tibetan medicine generally has the following characteristics:
first, tibetan medicine is mostly synthesized by several medicines, and is rarely single prescription. Many prescriptions have more than 25 dosage forms, and some dosage forms are even more than seventy-eight and one hundred dosage forms.
Secondly, collection of Tibetan medicine is different from that of traditional Chinese medicine. The traditional Chinese medicine is collected in the season, and the Tibetan medicine is collected when the content of the effective components of the medicinal materials is the highest. Herbs should be collected when plants grow most vigorously, so the efficacy is highest when they are used. Therefore, the medicine has excellent effect on treating diseases, and is basically collected once a year, and the collection difficulty is high, rare and precious.
Third, the Tibetan medicine preparation usually makes an individual treatment scheme according to the differences of the physique, illness state, environment and the like of patients, and the same diseases can have different Tibetan medicine treatment schemes on different patients.
Based on the above characteristics of Tibetan medicines, the preparation of Tibetan medicines (such as east Gu Jiuba, darcy mar and the like) is limited: the Tibetan medicine preparation adopts a plurality of raw materials, and has limited collection quantity, so that the Tibetan medicine preparation process needs to provide higher raw material management precision than the general pharmaceutical industry; the raw materials adopted in the preparation of part of Tibetan medicines are precious, rare and high in value, so that the Tibetan medicines are high in price; in treating the same diseases of different patients, different doses of Tibetan medicine agents can be prescribed, so that the suitability requirement of the dosage of the Tibetan medicine agents is required to be higher than that of the general pharmaceutical industry in the Tibetan medicine preparation process so as to meet different types of patients.
Therefore, how to realize the Tibetan medicine raw material management with higher precision, the Tibetan medicine price with lower cost and the Tibetan medicine dosage with higher suitability in the medicine preparation control process is a technical problem to be solved urgently.
Disclosure of Invention
The application mainly aims to provide a medicine preparation control method, a device, equipment and a storage medium, and aims to solve the technical problems that the existing Tibetan medicine preparation has low Tibetan medicine raw material management fineness and low Tibetan medicine dosage suitability, so that the Tibetan medicine price cannot be further reduced.
To achieve the above object, the present application provides a pharmaceutical preparation control method comprising the steps of:
acquiring medicine historical selling information of a plurality of medicine selling main bodies in different areas; the medicine historical vending information comprises medicine vending information recorded by each medicine issuing list in each medicine vending period, and the medicine vending information comprises a medicine dose actual value, a medicine dose theoretical value and vending associated information corresponding to the medicine dose theoretical value of a target medicine;
according to the selling associated information corresponding to the theoretical value of each medicine dose of the target medicine, a dose influence factor list storing the association relation between each medicine dose and the corresponding selling associated information is established;
acquiring the medicine raw material consumption used by preparing a target medicine in the latest medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the latest medicine preparation period;
according to the medicine raw material consumption used for preparing the target medicine in the latest medicine preparation period and the medicine raw material consumption of the current medicine preparation period, adjusting the actual medicine dosage value in the medicine selling period corresponding to the latest medicine preparation period by using a dosage influence factor list to obtain a medicine dosage preparation strategy of the current medicine preparation period;
and sending the medicine dose preparation strategy to a medicine preparation main body so that the medicine preparation main body executes medicine preparation according to the medicine dose preparation strategy.
Optionally, the selling the associated information includes: and a plurality of dose influencing factor combinations corresponding to the medicine dose theoretical values, wherein the medicine dose theoretical values are configured as medicine dose values corresponding to target patients generated in a medicine prescription according to the plurality of dose influencing factor combinations by doctors.
Optionally, the combination of the several dose influencing factors includes: patient-related information and environment-related information; wherein the patient-related information includes one or more of patient age, patient gender and patient physical index parameters, and the environment-related information includes one or more of environment parameters in which the patient is located.
Optionally, the drug dose actual value is configured to: and the medicine dosage value with the minimum medicine dosage is in all medicine dosage types with medicine dosages larger than the medicine dosage theoretical value in all medicine dosage types with corresponding medicine dosage in the medicine selling period.
Optionally, according to the selling associated information corresponding to the theoretical value of each medicine dose of the target medicine, a step of establishing a dose influencing factor list storing the association relation between each medicine dose and the corresponding selling associated information specifically includes:
extracting a medicine dose theoretical value and corresponding selling association information recorded by each medicine issuing list of a target medicine, merging and de-duplicating the dose influencing factors in the selling association information corresponding to the same medicine dose theoretical value, and obtaining a dose influencing factor combination corresponding to each medicine dose theoretical value;
and carrying out association storage on each medicine dose theoretical value and the corresponding dose influencing factor combination, and generating a dose influencing factor list storing association relation between each medicine dose and corresponding vending association information.
Optionally, the step of obtaining the medicine raw material consumption used by the target medicine prepared in the last medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the last medicine preparation period specifically includes:
calling a medicine preparation database storing the medicine raw material dosage used by a medicine preparation main body for preparing a target medicine in each medicine preparation period, and extracting the medicine raw material dosage used by the medicine preparation main body for preparing the target medicine in the last medicine preparation period from the medicine preparation database;
extracting the actual medicine dosage value of the medicine in the medicine selling period corresponding to the latest medicine preparation period from the medicine history selling information; the medicine selling period corresponding to the medicine preparation period is a period after the medicine preparation period is ended and before the next medicine preparation period is started on a time axis.
Optionally, according to the medicine raw material dosage used for preparing the target medicine in the last medicine preparation period and the medicine raw material dosage of the current medicine preparation period, adjusting the actual medicine dosage value in the medicine selling period corresponding to the last medicine preparation period by using the dosage influence factor list to obtain the medicine dosage preparation strategy step of the current medicine preparation period, specifically including:
according to the raw material ratio of the raw material dosage of the medicine used for preparing the target medicine in the latest medicine preparation period to the raw material dosage of the medicine in the current medicine preparation period;
extracting a medicine dose actual value and a dose influence factor combination recorded by each medicine prescription in a medicine selling period corresponding to the latest medicine preparation period, and classifying according to a plurality of dose influence factor combinations corresponding to the same medicine dose actual value to obtain classified category numbers;
taking the product of the classified category number and the raw material ratio as updated category number, and distributing a plurality of dose influence factor combinations in a dose influence factor list by utilizing the updated category number to obtain the drug dose type distributed in the current preparation period;
determining the preparation proportion of each medicine dosage type according to the number of times of occurrence of the dose influence factor combination corresponding to each medicine dosage type after being distributed in the medicine selling period corresponding to the latest medicine preparation period;
and generating a medicine dosage preparation strategy of the current medicine preparation period based on the medicine dosage type and the preparation proportion of the medicine dosage type of the current preparation period.
In addition, in order to achieve the above object, the present application also provides a medicine preparation control device including:
the first acquisition module is used for acquiring medicine history selling information of a plurality of medicine selling bodies in different areas; the medicine historical vending information comprises medicine vending information recorded by each medicine issuing list in each medicine vending period, and the medicine vending information comprises a medicine dose actual value, a medicine dose theoretical value and vending associated information corresponding to the medicine dose theoretical value of a target medicine;
the establishing module is used for establishing a dose influence factor list storing the association relation between each medicine dose and the corresponding selling association information according to the selling association information corresponding to the theoretical value of each medicine dose of the target medicine;
the second acquisition module is used for acquiring the medicine raw material consumption used for preparing the target medicine in the last medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the last medicine preparation period;
the adjusting module is used for adjusting the actual value of the medicine dosage in the medicine selling period corresponding to the latest medicine preparation period by utilizing the dosage influence factor list according to the medicine raw material dosage used for preparing the target medicine in the latest medicine preparation period and the medicine raw material dosage of the current medicine preparation period, so as to obtain a medicine dosage preparation strategy of the current medicine preparation period;
and the sending module is used for sending the medicine dosage preparation strategy to a medicine preparation main body so that the medicine preparation main body can execute medicine preparation according to the medicine dosage preparation strategy.
In addition, in order to achieve the above object, the present application also provides a medicine preparation control apparatus comprising: the medicine preparation control system comprises a memory, a processor and a medicine preparation control program stored in the memory and capable of running on the processor, wherein the medicine preparation control program realizes the steps of the medicine preparation control method when being executed by the processor.
In addition, in order to achieve the above object, the present application also provides a storage medium having stored thereon a medicine preparation control program which, when executed by a processor, implements the steps of the above medicine preparation control method.
The application has the beneficial effects that: the medicine preparation control method, the device, the equipment and the storage medium are provided, a dose influence factor list is established from medicine historical selling information, and then the medicine dose actual value of the latest medicine paper cup period is adjusted by utilizing the dose influence factor list to obtain a medicine dose preparation strategy of the current medicine preparation period, so that the management fineness of Tibetan medicine raw materials is improved, each patient can buy Tibetan medicine dose which is most suitable for the state of the patient, the suitability of the Tibetan medicine dose is improved, the medicine effect of the Tibetan medicine is further enhanced, and the Tibetan medicine price is further reduced.
Drawings
FIG. 1 is a schematic diagram of a device structure of a hardware operating environment according to an embodiment of the present application;
FIG. 2 is a schematic flow chart of an embodiment of a method for controlling the preparation of a pharmaceutical product according to the present application;
fig. 3 is a block diagram showing a medicine preparation control device according to an embodiment of the present application.
The achievement of the objects, functional features and advantages of the present application will be further described with reference to the accompanying drawings, in conjunction with the embodiments.
Detailed Description
It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the application.
The present application will be described in further detail with reference to the drawings and examples, in order to make the objects, technical solutions and advantages of the present application more apparent. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the application.
Referring to fig. 1, fig. 1 is a schematic diagram of an apparatus structure of a hardware running environment according to an embodiment of the present application.
As shown in fig. 1, the apparatus may include: a processor 1001, such as a CPU, a communication bus 1002, a user interface 1003, a network interface 1004, and a memory 1005. Wherein the communication bus 1002 is used to enable connected communication between these components. The user interface 1003 may include a Display, an input unit such as a Keyboard (Keyboard), and the optional user interface 1003 may also include a standard wired interface, a wireless interface. The network interface 1004 may optionally include a standard wired interface, a wireless interface (e.g., WI-FI interface). The memory 1005 may be a high-speed RAM memory or a stable memory (non-volatile memory), such as a disk memory. The memory 1005 may also optionally be a storage device separate from the processor 1001 described above.
It will be appreciated by those skilled in the art that the arrangement of the apparatus shown in fig. 1 is not limiting and may include more or fewer components than shown, or certain components may be combined, or a different arrangement of components.
As shown in fig. 1, an operating system, a network communication module, a user interface module, and a medicine preparation control program may be included in a memory 1005, which is a type of computer storage medium.
In the terminal shown in fig. 1, the network interface 1004 is mainly used for connecting to a background server and performing data communication with the background server; the user interface 1003 is mainly used for connecting a client (user side) and performing data communication with the client; and the processor 1001 may be configured to call a medicine preparation control program stored in the memory 1005 and perform the following operations:
acquiring medicine historical selling information of a plurality of medicine selling main bodies in different areas; the medicine historical vending information comprises medicine vending information recorded by each medicine issuing list in each medicine vending period, and the medicine vending information comprises a medicine dose actual value, a medicine dose theoretical value and vending associated information corresponding to the medicine dose theoretical value of a target medicine;
according to the selling associated information corresponding to the theoretical value of each medicine dose of the target medicine, a dose influence factor list storing the association relation between each medicine dose and the corresponding selling associated information is established;
acquiring the medicine raw material consumption used by preparing a target medicine in the latest medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the latest medicine preparation period;
according to the medicine raw material consumption used for preparing the target medicine in the latest medicine preparation period and the medicine raw material consumption of the current medicine preparation period, adjusting the actual medicine dosage value in the medicine selling period corresponding to the latest medicine preparation period by using a dosage influence factor list to obtain a medicine dosage preparation strategy of the current medicine preparation period;
and sending the medicine dose preparation strategy to a medicine preparation main body so that the medicine preparation main body executes medicine preparation according to the medicine dose preparation strategy.
The specific embodiment of the present application applied to the apparatus is substantially the same as each embodiment of the following method for controlling the preparation of the application medicine, and will not be described herein.
The embodiment of the application provides a medicine preparation control method, and referring to fig. 2, fig. 2 is a schematic flow chart of an embodiment of the medicine preparation control method.
In this embodiment, the medicine preparation control method includes the following steps:
s100: acquiring medicine historical selling information of a plurality of medicine selling main bodies in different areas; the medicine historical vending information comprises medicine vending information recorded by each medicine issuing list in each medicine vending period, and the medicine vending information comprises a medicine dose actual value, a medicine dose theoretical value and vending associated information corresponding to the medicine dose theoretical value of a target medicine;
s200: according to the selling associated information corresponding to the theoretical value of each medicine dose of the target medicine, a dose influence factor list storing the association relation between each medicine dose and the corresponding selling associated information is established;
s300: acquiring the medicine raw material consumption used by preparing a target medicine in the latest medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the latest medicine preparation period;
s400: according to the medicine raw material consumption used for preparing the target medicine in the latest medicine preparation period and the medicine raw material consumption of the current medicine preparation period, adjusting the actual medicine dosage value in the medicine selling period corresponding to the latest medicine preparation period by using a dosage influence factor list to obtain a medicine dosage preparation strategy of the current medicine preparation period;
s500: and sending the medicine dose preparation strategy to a medicine preparation main body so that the medicine preparation main body executes medicine preparation according to the medicine dose preparation strategy.
It should be noted that the preparation process of the existing Tibetan medicines (such as east Gu Jiuba, darcy mar and the like) has the following limitations: the Tibetan medicine preparation adopts a plurality of raw materials, and has limited collection quantity, so that the Tibetan medicine preparation process needs to provide higher raw material management precision than the general pharmaceutical industry; the raw materials adopted in the preparation of part of Tibetan medicines are precious, rare and high in value, so that the Tibetan medicines are high in price; in treating the same diseases of different patients, different doses of Tibetan medicine agents can be prescribed, so that the suitability requirement of the dosage of the Tibetan medicine agents is required to be higher than that of the general pharmaceutical industry in the Tibetan medicine preparation process so as to meet different types of patients.
Therefore, in this embodiment, by extracting, from the medicine history vending information of the plurality of medicine vending bodies, the medicine dose actual value, the medicine dose theoretical value, and the vending association information corresponding to the medicine dose theoretical value of the target medicine recorded in each medicine dispensing order in each medicine vending period, according to the vending association information, a dose influencing factor list storing association relations between each medicine dose and the corresponding vending association information is established, where the dose influencing factor list may record association relations between the vending association information corresponding to each medicine dose. In practical applications, each medicine selling period is the selling time in two adjacent medicine preparing periods, that is, the target medicine prepared in the last medicine preparing period is usually sold in the last medicine selling period. Therefore, after the dosage influence factor list is obtained, the medicine dosage actual value in the medicine selling period corresponding to the latest medicine preparation period can be adjusted by using the dosage influence factor list, the medicine dosage preparation strategy of the current medicine preparation period is obtained, and the medicine dosage preparation strategy of the current medicine preparation period is obtained.
In a preferred embodiment, the vending associated information includes: and a plurality of dose influencing factor combinations corresponding to the medicine dose theoretical values, wherein the medicine dose theoretical values are configured as medicine dose values corresponding to target patients generated in a medicine prescription according to the plurality of dose influencing factor combinations by doctors. Wherein the combination of the several dose influencing factors comprises: patient-related information and environment-related information; wherein the patient-related information includes one or more of patient age, patient gender and patient physical index parameters, and the environment-related information includes one or more of environment parameters in which the patient is located.
In a preferred embodiment, the drug dose actual value is configured to: and the medicine dosage value with the minimum medicine dosage is in all medicine dosage types with medicine dosages larger than the medicine dosage theoretical value in all medicine dosage types with corresponding medicine dosage in the medicine selling period. Since the medicine dose that is just matched with the patient is not necessarily present in all the medicine dose categories included in the medicine vending cycle, in order to ensure the medicine effect, in practical application, a medicine dose of a medicine dose category whose medicine dose actual value is closest to the medicine dose and greater than the medicine dose theoretical value is selected.
In a preferred embodiment, according to the sales associated information corresponding to the theoretical value of each drug dose of the target drug, a step of establishing a dose influencing factor list storing the association relation between each drug dose and the corresponding sales associated information specifically includes: extracting a medicine dose theoretical value and corresponding selling association information recorded by each medicine issuing list of a target medicine, merging and de-duplicating the dose influencing factors in the selling association information corresponding to the same medicine dose theoretical value, and obtaining a dose influencing factor combination corresponding to each medicine dose theoretical value; and carrying out association storage on each medicine dose theoretical value and the corresponding dose influencing factor combination, and generating a dose influencing factor list storing association relation between each medicine dose and corresponding vending association information. Therefore, the obtained dose influence factor list records the association relation between a plurality of medicine doses and corresponding vending association information.
In a preferred embodiment, the step of obtaining the medicine raw material amount used for preparing the target medicine in the last medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the last medicine preparation period specifically includes: calling a medicine preparation database storing the medicine raw material dosage used by a medicine preparation main body for preparing a target medicine in each medicine preparation period, and extracting the medicine raw material dosage used by the medicine preparation main body for preparing the target medicine in the last medicine preparation period from the medicine preparation database; extracting the actual medicine dosage value of the medicine in the medicine selling period corresponding to the latest medicine preparation period from the medicine history selling information; the medicine selling period corresponding to the medicine preparation period is a period after the medicine preparation period is ended and before the next medicine preparation period is started on a time axis.
In a preferred embodiment, according to the medicine raw material amount used for preparing the target medicine in the last medicine preparation period and the medicine raw material amount of the current medicine preparation period, the actual medicine dosage value in the medicine selling period corresponding to the last medicine preparation period is adjusted by using the dosage influence factor list, so as to obtain the medicine dosage preparation strategy step of the current medicine preparation period, which specifically includes: according to the raw material ratio of the raw material dosage of the medicine used for preparing the target medicine in the latest medicine preparation period to the raw material dosage of the medicine in the current medicine preparation period; extracting a medicine dose actual value and a dose influence factor combination recorded by each medicine prescription in a medicine selling period corresponding to the latest medicine preparation period, and classifying according to a plurality of dose influence factor combinations corresponding to the same medicine dose actual value to obtain classified category numbers; taking the product of the classified category number and the raw material ratio as updated category number, and distributing a plurality of dose influence factor combinations in a dose influence factor list by utilizing the updated category number to obtain the drug dose type distributed in the current preparation period; determining the preparation proportion of each medicine dosage type according to the number of times of occurrence of the dose influence factor combination corresponding to each medicine dosage type after being distributed in the medicine selling period corresponding to the latest medicine preparation period; and generating a medicine dosage preparation strategy of the current medicine preparation period based on the medicine dosage type and the preparation proportion of the medicine dosage type of the current preparation period.
In the embodiment, in the medicine selling period corresponding to the latest medicine preparation period, the medicine dose actual value and the dose influencing factor combination recorded by each medicine prescription are extracted and classified, and the classified category number is multiplied by the raw material ratio to update the category number, so that the medicine dose type and the preparation proportion of each medicine dose type are obtained. Therefore, the medicine dosage preparation strategy of the latest medicine preparation period is adjusted through the dosage influence factor list, so that the medicine dosage preparation strategy more suitable for patients is obtained, the dosage of the medicine prepared in the current medicine preparation period is most suitable for the requirements of the current patients, and each patient can buy the Tibetan medicine dosage most suitable for the state of the patient.
In this embodiment, a drug preparation control method is provided, a dose influencing factor list is established from drug history vending information, and then the drug preparation strategy of the current drug preparation period is obtained by adjusting the dose influencing factor list according to the actual value of the drug dose in the last drug paper cup period, so that the management fineness of Tibetan drug raw materials is improved, each patient can buy the Tibetan drug dose which is most suitable for the state of the patient, the suitability of the Tibetan drug dose is improved, the drug effect of the Tibetan drug is further enhanced, and the price of the Tibetan drug is further reduced.
Referring to fig. 3, fig. 3 is a block diagram showing the construction of an embodiment of the drug preparation control device of the present application.
As shown in fig. 3, the medicine preparation control device according to the embodiment of the present application includes:
the first acquiring module 10 is configured to acquire medicine history vending information of a plurality of medicine vending bodies in different areas; the medicine historical vending information comprises medicine vending information recorded by each medicine issuing list in each medicine vending period, and the medicine vending information comprises a medicine dose actual value, a medicine dose theoretical value and vending associated information corresponding to the medicine dose theoretical value of a target medicine;
the establishing module 20 is configured to establish a dose influencing factor list storing an association relationship between each drug dose and corresponding vending association information according to vending association information corresponding to a theoretical value of each drug dose of the target drug;
a second obtaining module 30, configured to obtain an actual drug dosage value when the drug raw material amount used for preparing the target drug in the last drug preparation cycle and the drug vending cycle corresponding to the last drug preparation cycle;
an adjustment module 40, configured to adjust, according to the amount of medicine raw material used for preparing the target medicine in the last medicine preparation period and the amount of medicine raw material in the current medicine preparation period, an actual value of a medicine dose in a medicine vending period corresponding to the last medicine preparation period by using a dose influencing factor list, so as to obtain a medicine dose preparation policy of the current medicine preparation period;
a sending module 50, configured to send the drug dose preparation policy to a drug preparation subject, so that the drug preparation subject performs drug preparation according to the drug dose preparation policy.
Other embodiments or specific implementation manners of the drug preparation control device of the present application may refer to the above method embodiments, and are not described herein.
Furthermore, the present application also proposes a medicine preparation control device comprising: the medicine preparation control system comprises a memory, a processor and a medicine preparation control program stored in the memory and capable of running on the processor, wherein the medicine preparation control program realizes the steps of the medicine preparation control method when being executed by the processor.
The specific implementation of the drug preparation control device of the present application is basically the same as the above examples of the drug preparation control method, and will not be described here again.
Furthermore, the present application also proposes a readable storage medium comprising a computer readable storage medium having stored thereon a pharmaceutical preparation control program. The readable storage medium may be a Memory 1005 in the terminal of fig. 1, or may be at least one of a ROM (Read-Only Memory)/RAM (Random Access Memory ), a magnetic disk, and an optical disk, and the readable storage medium includes a plurality of instructions for causing a drug preparation control device having a processor to perform the drug preparation control method according to the embodiments of the present application.
The specific implementation manner of the readable storage medium of the present application is basically the same as the above embodiments of the drug preparation control method, and will not be described herein.
It is appreciated that in the description herein, reference to the terms "one embodiment," "another embodiment," "other embodiments," or "first through nth embodiments," etc., means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the application. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiments or examples. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
It should be noted that, in this document, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or system that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or system. Without further limitation, an element defined by the phrase "comprising one … …" does not exclude the presence of other like elements in a process, method, article, or system that comprises the element.
The foregoing embodiment numbers of the present application are merely for the purpose of description, and do not represent the advantages or disadvantages of the embodiments.
From the above description of the embodiments, it will be clear to those skilled in the art that the above-described embodiment method may be implemented by means of software plus a necessary general hardware platform, but of course may also be implemented by means of hardware, but in many cases the former is a preferred embodiment. Based on such understanding, the technical solution of the present application may be embodied essentially or in a part contributing to the prior art in the form of a software product stored in a storage medium (e.g. ROM/RAM, magnetic disk, optical disk) as described above, comprising instructions for causing a terminal device (which may be a mobile phone, a computer, a server, an air conditioner, or a network device, etc.) to perform the method according to the embodiments of the present application.
The foregoing description is only of the preferred embodiments of the present application, and is not intended to limit the scope of the application, but rather is intended to cover any equivalents of the structures or equivalent processes disclosed herein or in the alternative, which may be employed directly or indirectly in other related arts.
Claims (10)
1. A pharmaceutical preparation control method, characterized in that the method comprises the steps of:
acquiring medicine historical selling information of a plurality of medicine selling main bodies in different areas; the medicine historical vending information comprises medicine vending information recorded by each medicine issuing list in each medicine vending period, and the medicine vending information comprises a medicine dose actual value, a medicine dose theoretical value and vending associated information corresponding to the medicine dose theoretical value of a target medicine;
according to the selling associated information corresponding to the theoretical value of each medicine dose of the target medicine, a dose influence factor list storing the association relation between each medicine dose and the corresponding selling associated information is established;
acquiring the medicine raw material consumption used by preparing a target medicine in the latest medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the latest medicine preparation period;
according to the medicine raw material consumption used for preparing the target medicine in the latest medicine preparation period and the medicine raw material consumption of the current medicine preparation period, adjusting the actual medicine dosage value in the medicine selling period corresponding to the latest medicine preparation period by using a dosage influence factor list to obtain a medicine dosage preparation strategy of the current medicine preparation period;
and sending the medicine dose preparation strategy to a medicine preparation main body so that the medicine preparation main body executes medicine preparation according to the medicine dose preparation strategy.
2. The medicine preparation control method of claim 1, wherein the vending associated information comprises: and a plurality of dose influencing factor combinations corresponding to the medicine dose theoretical values, wherein the medicine dose theoretical values are configured as medicine dose values corresponding to target patients generated in a medicine prescription according to the plurality of dose influencing factor combinations by doctors.
3. The pharmaceutical product manufacturing control method of claim 2, wherein the combination of several dose influencing factors comprises: patient-related information and environment-related information; wherein the patient-related information includes one or more of patient age, patient gender and patient physical index parameters, and the environment-related information includes one or more of environment parameters in which the patient is located.
4. A drug preparation control method according to claim 3, wherein the drug dose actual value is configured to: and the medicine dosage value with the minimum medicine dosage is in all medicine dosage types with medicine dosages larger than the medicine dosage theoretical value in all medicine dosage types with corresponding medicine dosage in the medicine selling period.
5. The medicine preparation control method according to claim 4, wherein the step of creating the dose influencing factor list storing the association relation between each medicine dose and the corresponding sales association information according to the sales association information corresponding to each medicine dose theoretical value of the target medicine specifically comprises:
extracting a medicine dose theoretical value and corresponding selling association information recorded by each medicine issuing list of a target medicine, merging and de-duplicating the dose influencing factors in the selling association information corresponding to the same medicine dose theoretical value, and obtaining a dose influencing factor combination corresponding to each medicine dose theoretical value;
and carrying out association storage on each medicine dose theoretical value and the corresponding dose influencing factor combination, and generating a dose influencing factor list storing association relation between each medicine dose and corresponding vending association information.
6. The medicine preparation control method according to claim 5, wherein the step of obtaining the medicine raw material amount used for preparing the target medicine in the last medicine preparation cycle and the medicine dosage actual value at the time of the medicine selling cycle corresponding to the last medicine preparation cycle specifically comprises:
calling a medicine preparation database storing the medicine raw material dosage used by a medicine preparation main body for preparing a target medicine in each medicine preparation period, and extracting the medicine raw material dosage used by the medicine preparation main body for preparing the target medicine in the last medicine preparation period from the medicine preparation database;
extracting the actual medicine dosage value of the medicine in the medicine selling period corresponding to the latest medicine preparation period from the medicine history selling information; the medicine selling period corresponding to the medicine preparation period is a period after the medicine preparation period is ended and before the next medicine preparation period is started on a time axis.
7. The medicine preparation control method according to claim 6, wherein the medicine preparation strategy step of obtaining the current medicine preparation cycle by adjusting the actual value of the medicine dosage at the time of the medicine selling cycle corresponding to the latest medicine preparation cycle using the dosage-affecting factor list according to the medicine raw material amount used for preparing the target medicine at the latest medicine preparation cycle and the medicine raw material amount of the current medicine preparation cycle, specifically comprises:
according to the raw material ratio of the raw material dosage of the medicine used for preparing the target medicine in the latest medicine preparation period to the raw material dosage of the medicine in the current medicine preparation period;
extracting a medicine dose actual value and a dose influence factor combination recorded by each medicine prescription in a medicine selling period corresponding to the latest medicine preparation period, and classifying according to a plurality of dose influence factor combinations corresponding to the same medicine dose actual value to obtain classified category numbers;
taking the product of the classified category number and the raw material ratio as updated category number, and distributing a plurality of dose influence factor combinations in a dose influence factor list by utilizing the updated category number to obtain the drug dose type distributed in the current preparation period;
determining the preparation proportion of each medicine dosage type according to the number of times of occurrence of the dose influence factor combination corresponding to each medicine dosage type after being distributed in the medicine selling period corresponding to the latest medicine preparation period;
and generating a medicine dosage preparation strategy of the current medicine preparation period based on the medicine dosage type and the preparation proportion of the medicine dosage type of the current preparation period.
8. A medicine preparation control device, characterized by comprising:
the first acquisition module is used for acquiring medicine history selling information of a plurality of medicine selling bodies in different areas; the medicine historical vending information comprises medicine vending information recorded by each medicine issuing list in each medicine vending period, and the medicine vending information comprises a medicine dose actual value, a medicine dose theoretical value and vending associated information corresponding to the medicine dose theoretical value of a target medicine;
the establishing module is used for establishing a dose influence factor list storing the association relation between each medicine dose and the corresponding selling association information according to the selling association information corresponding to the theoretical value of each medicine dose of the target medicine;
the second acquisition module is used for acquiring the medicine raw material consumption used for preparing the target medicine in the last medicine preparation period and the medicine dosage actual value in the medicine selling period corresponding to the last medicine preparation period;
the adjusting module is used for adjusting the actual value of the medicine dosage in the medicine selling period corresponding to the latest medicine preparation period by utilizing the dosage influence factor list according to the medicine raw material dosage used for preparing the target medicine in the latest medicine preparation period and the medicine raw material dosage of the current medicine preparation period, so as to obtain a medicine dosage preparation strategy of the current medicine preparation period;
and the sending module is used for sending the medicine dosage preparation strategy to a medicine preparation main body so that the medicine preparation main body can execute medicine preparation according to the medicine dosage preparation strategy.
9. A medicine preparation control device, characterized in that the medicine preparation control device comprises: a memory, a processor, and a drug preparation control program stored on the memory and executable on the processor, which when executed by the processor, implements the steps of the drug preparation control method of any one of claims 1 to 7.
10. A storage medium having stored thereon a drug preparation control program which, when executed by a processor, implements the steps of the drug preparation control method of any one of claims 1 to 7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311379288.3A CN117153324B (en) | 2023-10-24 | 2023-10-24 | Medicine preparation control method, device, equipment and storage medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311379288.3A CN117153324B (en) | 2023-10-24 | 2023-10-24 | Medicine preparation control method, device, equipment and storage medium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117153324A true CN117153324A (en) | 2023-12-01 |
| CN117153324B CN117153324B (en) | 2024-02-06 |
Family
ID=88884472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311379288.3A Active CN117153324B (en) | 2023-10-24 | 2023-10-24 | Medicine preparation control method, device, equipment and storage medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117153324B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1760902A (en) * | 2005-11-11 | 2006-04-19 | 杭州电子科技大学 | Method for optimizing scheduling system by technical imitaitng real flow |
| US20100312578A1 (en) * | 2009-06-09 | 2010-12-09 | Wellpartner Incorporated | System and method for prepurchased replenishment of pharmaceuticals |
| CN103271921A (en) * | 2013-05-10 | 2013-09-04 | 华南农业大学 | Preparation method of compound solution of toltrazuril and diclazuril and application thereof |
| CN114331043A (en) * | 2021-12-10 | 2022-04-12 | 壹药网科技(上海)股份有限公司 | Dynamic planning and allocating system and method for centralized medicine storage platform |
| CN114529086A (en) * | 2022-02-21 | 2022-05-24 | 卫宁健康科技集团股份有限公司 | Medicine data processing method, device and equipment |
| CN115204940A (en) * | 2022-06-22 | 2022-10-18 | 北京森科医药有限公司 | Medicine selling method, device, equipment and computer readable storage medium |
-
2023
- 2023-10-24 CN CN202311379288.3A patent/CN117153324B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1760902A (en) * | 2005-11-11 | 2006-04-19 | 杭州电子科技大学 | Method for optimizing scheduling system by technical imitaitng real flow |
| US20100312578A1 (en) * | 2009-06-09 | 2010-12-09 | Wellpartner Incorporated | System and method for prepurchased replenishment of pharmaceuticals |
| CN103271921A (en) * | 2013-05-10 | 2013-09-04 | 华南农业大学 | Preparation method of compound solution of toltrazuril and diclazuril and application thereof |
| CN114331043A (en) * | 2021-12-10 | 2022-04-12 | 壹药网科技(上海)股份有限公司 | Dynamic planning and allocating system and method for centralized medicine storage platform |
| CN114529086A (en) * | 2022-02-21 | 2022-05-24 | 卫宁健康科技集团股份有限公司 | Medicine data processing method, device and equipment |
| CN115204940A (en) * | 2022-06-22 | 2022-10-18 | 北京森科医药有限公司 | Medicine selling method, device, equipment and computer readable storage medium |
Non-Patent Citations (4)
| Title |
|---|
| LIU XIAOZHEN等: "Preparation and Performance of Controlled-Release Tablets of Sasanquasaponin-Casein", 《SPECTROSCOPY AND SPECTRAL ANALYSIS》, vol. 32, no. 06, pages 1650 - 1653 * |
| ZABEEULLA等: "An Effective Review of The Problems and Opportunities of The Supply Chain for Pharmaceuticals", 《2022 11TH INTERNATIONAL CONFERENCE ON SYSTEM MODELING & ADVANCEMENT IN RESEARCH TRENDS (SMART)》, pages 799 - 804 * |
| 伍金丹增等: "藏药三味甘露散的方剂来源、炮制工艺及配伍特点综述", 《亚太传统医药》, vol. 18, no. 12, pages 10 - 13 * |
| 李硕: "长春花属生物碱抗肿瘤药物的半合成研究", 《中国博士学位论文全文数据库 工程科技Ⅰ辑》, no. 12, pages 016 - 21 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117153324B (en) | 2024-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ford et al. | Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men | |
| Lopman et al. | Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States | |
| Simon et al. | Accelerated titration designs for phase I clinical trials in oncology | |
| Prentice et al. | Estrogen plus progestin therapy and breast cancer in recently postmenopausal women | |
| Martin et al. | The impact of implementing a more restrictive prescription limit on Medicaid recipients: effects on cost, therapy, and out-of-pocket expenditures | |
| Kim | Blues from the neighborhood? Neighborhood characteristics and depression | |
| Curto et al. | Regional tenders on biosimilars in Italy: an empirical analysis of awarded prices | |
| CN108876486A (en) | The lottery drawing method and device of personalized customization winning probability | |
| Esimone et al. | Utilization of antimicrobial agents with and without prescription by out-patients in selected pharmacies in South-eastern Nigeria | |
| Klassing et al. | Evaluation of pharmacist-initiated interventions on vaccination rates in patients with asthma or COPD | |
| Driessen et al. | Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: an extended cost-effectiveness analysis | |
| Preisser et al. | Detecting patterns of occupational illness clustering with alternating logistic regressions applied to longitudinal data | |
| Zainelabdeen et al. | The impact of grazing on the grass composition in temperate grassland | |
| Irrera et al. | PDRN, a bioactive natural compound, ameliorates imiquimod-induced psoriasis through NF-κB pathway inhibition and Wnt/β-Catenin signaling modulation | |
| Liang et al. | User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives | |
| CN117153324B (en) | Medicine preparation control method, device, equipment and storage medium | |
| Rayburn et al. | Light interception and the growth of pastures under ideal and stressful growing conditions on the allegheny plateau | |
| Jiang et al. | The impact of the reference pricing policy in China on drug procurement and cost | |
| Xu et al. | Health financing and access to effective interventions | |
| Wang et al. | Corticosteroid injection alone or combined with surgical excision of keloids versus other therapies including ionising radiotherapy: a systematic review and meta-analysis of randomised controlled trials | |
| Wagner et al. | Changing patient consultation patterns in primary care: an investigation of uptake of the Minor Ailments Service in Scotland | |
| Marđetko et al. | Influence of generic reference pricing on medicine cost in Slovenia: a retrospective study | |
| Burnett et al. | Lucerne (Medicago sativa L.) persistence remains unchanged under variable cutting regimes | |
| Chaushu et al. | Age-Related palatal wound healing: An experimental in vivo study | |
| Salvesen Blix | Measurement units of drug utilization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |